Wednesday May 25, 2022
Beating breathlessness: The impact of dyspnoea in COPD
This episode’s guest on the Medical Insider COPD podcast is Dr Barbara Yawn, a primary care physician and COPD clinical researcher. Join her and Dr Richard Russell as they explore the impact of breathlessness from the patient perspective, discussing physical activity, pharmacotherapy and mortality. 1-4 Dr Russell will then present the key takeaways from a new and exciting publication on the real-world impact of exacerbations on quality of life. 5 This is followed by a dive into the world of social media, where patients with COPD are discussing the use of face masks to prevent the transmission of respiratory viruses this winter.
1 Global Initiative for Chronic Obstructive Lung Disease. Updated 2022. Available here. Last accessed: November 2022
2 Hutchinson A, et al. Eur Respir J 2018;51:1701477;
3 Waschki B, et al. Chest 2011;140:331-332;
4 Watz H, et al. Eur Respir J 2014;44:1521;
5 Stöber A, et al. Int J Chron Obstruct Pulmon Dis 2021;16:2637-2651
Disclosures
Dr Yawn reports advisory board membership and consultancy fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Teva. She also reports research support for investigator-initiated research from GlaxoSmithKline.
Bio:
Dr Barbara Yawn |
This series of podcasts are intended for healthcare professionals only.
The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.
Copyright © 2021, Boehringer Ingelheim Group of Companies. All rights reserved.